When selecting the signaling pathways to be studied, based on the column length and P-value size, as well as the direction of the study, the final selection of IL-17 signaling pathway, lipid and atherosclerosis, TNF signaling pathway, Toll-like receptor (TLR) signaling pathway, containing 34 core targets and 18 corresponding active compounds, were selected for molecular docking. This evidence concerns the gene IL17A and atherosclerosis.